Coronavirius - COVID-19 Information


The World Health Organization (WHO) has declared the outbreak of respiratory disease caused by a novel coronavirus a pandemic.

Please reference the CDC, the Ohio Department of Health and your local community health districts for the most up to date information for your practice location(s). Please follow the links below:

                     CURRENT SIGNED OHIO HEALTH ORDER

 

 

CARES Act Provider Relief Fund - The CARES Act Provider Relief Fund Payment Attestation Portal is now open. Providers who have been allocated a payment must sign an attestation confirming receipt of the funds and agree to the terms and conditions within 30 days of payment. - click here

 

**Updated COVID-19 Related Resource Pages** click on the links

  • June 4, 2020 Update, Congress passes - PPP FLEXIBILITY ACT 

  • CMS Recommendations as of June 8, 2020

  • APMA COVID-19 Resource Page

  • APMA Information Regarding Re-Opening Your Practice

  • APMA Working With American Academy of Dermatology (AAD) on COVID-19 Registry

     

    **BWC News Release UPDATES**

    BWC Extends Premium Due Date Until September 1st ( 2nd deferral during the COVID-19 pandemic)

    The Ohio Bureau of Worker's Compensation (BWC) is deferring the due date for employers to pay their June, July, and August premium installments until September 1, 2020.  This was done under the Governor's Responsible ReStartOhio Plan, so employers may focus on opening their businesses while keeping Ohioans safe.

    Among several actions to help the business community’s bottom line, BWC sent Ohio’s private and public employers nearly $1.6 billion in dividends in late April thanks to strong investment returns, declining injury claims, and other costs savings. The agency is also sending at least 2 million face coverings to employers and their workforce to weaken the spread of the coronavirus under its Protecting Ohio’s Workforce — We’ve Got You Covered plan.

    For more on BWC as it relates to COVID-19, please visit bwc.ohio.gov or email us at BWCCOVID19@bwc.state.oh.us

    For more on COVID-19, including prevention guidelines and its impact on Ohio, visit the Ohio Department of Health website coronavirus.ohio.gov.


Ohio Department of Health

 

CLICK HERE to go directly to the COVID-19 page on ODH website for Healthcare Provider information


Telemedicine

Ohio law defines telemedicine as the practice of medicine through the use of any communication, including oral, written or electronic communication, by a physician located outside of this state.  Pursuant to Ohio law, any practitioner, including physicians, podiatric physicians, nurse practitioners and physician assistants who treat a patient located in Ohio through telemedicine, must be licensed for full practice by the Ohio Board or possess a limited Ohio telemedicine certificate.

Under the Ohio Board’s new regulations, practitioners may issue a prescription for a non-controlled medication to a person whom the practitioner has never conducted a physical examination and who is located at a remote location so long as the following requirements are satisfied:

  1. The practitioner must establish the patient’s identity and physical location;
  2. The practitioner shall obtain the patient’s informed consent for treatment;
  3. The practitioner shall request the patient’s consent to forward the medical record to the patient’s primary care or other appropriate health care provider, if applicable, or refer the patient to an appropriate health care provider or facility;
  4. The practitioner shall complete a medical evaluation appropriate for the patient’s condition, which meets appropriate standards of care and may include portions of the evaluation having been conducted by other health care providers acting within their professional scope;
  5. The practitioner shall establish or confirm a diagnosis and treatment plan, including documentation regarding the necessity for the utilization of any prescription drug;
  6. The practitioner shall document the patient’s consent to treatment, pertinent history, evaluation, diagnosis, treatment plan, underlying conditions, contraindications and any referrals to appropriate health care providers, including primary care providers and healthcare facilities;
  7. In accordance with the standards of care, the practitioner shall provide appropriate follow-up care or recommend follow-up care with the patient’s primary care provider or other appropriate health care provider or facility; and
  8. The practitioner shall make a medical record of the visit available to the patient.

Additionally, controlled substances may be prescribed by a practitioner to a person for whom the practitioner has not performed a physical examination and who is located in a remote location, so long as the practitioner has met the steps outlined above for authorizing non-controlled substances and one of the following situations exists:

  • The person is an “active patient” of a health care provider who is a colleague of the practitioner, and the controlled substances are provided through an on-call or cross coverage arrangement between the health care providers. Note “active patient” means the practitioner conducted at least one in-person medical evaluation within the previous 24 months;
  • The physician is the medical director, hospice physician or attending physician of a hospice, and the controlled substance is prescribed to a hospice-enrolled patient;
  • The physician is the medical director or attending physician at a state-licensed institutional facility, and the controlled substance is prescribed to a facility inpatient or resident;
  • The patient is in a hospital or clinic registered with the United States Drug Enforcement Administration (DEA) to provide controlled substances when treated by an Ohio licensed physician or other DEA-registered provider furnishing services in accordance with the current standards of practice;
  • The patient is being treated by, and in the physical presence of, an Ohio-licensed physician or other DEA-registered provider and provides services in accordance with the current standards of practice; and
  • The physician has received a special DEA registration to provide controlled substances in the particular situation.

​The Ohio Board’s rules are consistent with changes seen in other states where the law allows for a relaxation of in-person examination requirements to facilitate expanded use of telemedicine.  Even so, practitioners should be aware the standard of care must always be maintained regardless of the method with which treatment is provided to a patient.


ADDITIONAL INFORMATION FROM THE CDC :

From the CDC website: Interim Infection Prevention and Control Recommendations for Patients with Suspected or Confirmed Coronavirus Disease 2019 (COVID-19) in Healthcare Settings

The CDC website has an abundance of information concerning COVID-19, please follow this link to the CDC website for the full webpage of information regarding healthcare setting recommendations: https://www.cdc.gov/coronavirus/2019-ncov/infection-control/control-recommendations.html

This link to the CDC website, includes information about long-term care treatment facilities: https://www.cdc.gov/coronavirus/2019-ncov/healthcare-facilities/prevent-spread-in-long-term-care-facilities.html

 

Interim Guidance for Implementing Home Care of People Not Requiring Hospitalization for COVID-19

CDC has developed interim guidance for staff at local and state health departments, infection prevention and control professionals, healthcare providers, and healthcare workers who are coordinating the home care and isolation of people who are confirmed to have, or being evaluated for (COVID-19 (see Criteria to Guide Evaluation of Patients Under Investigation (PUI) for COVID-19).
Interim Guidance for Implementing Home Care of People Not Requiring Hospitalization forCOVID-19)



Recommended Resources